Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 932 results for "glenmark"

This is going to be challenging year in the US market: Glenn S...

As the chairman and managing director of Glenmark Pharmaceuticals, Glenn Saldanha oversees a fast-growing organisation that spans from an India-focused branded generics business to a significant export market across major emerging and developed economies. DNA, 3 hours ago

107 images for glenmark, 3 days ago
Pharma Letter, 2 days ago, 3 days ago
Bio Spectrum Asia, 1 week ago
NDTV, 1 week ago
European Pharmaceutical Manufacturer, 1 week ago
Sify, 2 days ago, 1 week ago
NDTV, 3 days ago
NDTV Profit, 3 days ago

Buy Glenmark Pharma Ltd at a target of Rs 680: Mitesh Thacker

Follow this section for latest news on Views/Recommendations EmailRSS Have something to say? Post your comment Comments are moderated and will be allowed if they are about the topic and not abusive. Characters remaining ( 1500 ) To post this comment you must ...
 Economic Times3 hours ago Buy Glenmark with a target Rs 630: Mitesh Thacker  Economic Times4 days ago Buy Glenmark at a target of Rs 715: Mitesh Thacker  Economic Times3 days ago Buy Glenmark with a target Rs 615-620: Prakash Gaba  Economic Times3 days ago

Glenmark net soars 44% in April-June

MUMBAI: Glenmark Pharma reported a 44% jump in consolidated net profit at Rs 185 crore for the first quarter ended June 30, 2014. The company had posted a net profit of Rs 129 crore in the corresponding quarter previous year. Consolidated net sales ...
 Times of India3 days ago Glenmark net profit increases 43.85% in Q1  Livemint.com3 days ago Glenmark net profit surges by 43.7% in Q1  PharmaBiz3 days ago Glenmark Pharma Q1 Net up 43.7 pc at Rs 184.8 crore  Business Standard3 days ago

Glenmark Pharmaceuticals To Build its First Facility in the US

Mumbai India-based Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the U.S. The facility will be situated in Monroe, North Carolina, at the Monroe Corporate ...
 CoStar Group3 days ago Glenmark to set up new manufacturing facility in US  Individual.com5 days ago Glenmark Pharma to build new manufacturing plant in US  Pharmaceutical Business Review6 days ago Pharmaceuticals Newsletter – July 14 to 18, 2014  India Infoline1 week ago
Bio Spectrum Asia

Glenmark Generics receives ANDA approval

Telmisartan is Glenmark's generic version of Boehringer Ingelheim's Micardis Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. ...
 Express Pharma5 days ago Glenmark receives ANDA nod for Telmisartan  Bio Spectrum Asia1 week ago Glenmark gets USFDA approval for skin infection cream  VC Circle1 week ago Glenmark Generics receives approval for Fluocinonide cream  Express Pharma1 week ago
Money Control

Stocks in news: Wipro, SKS, Ambuja, Ranbaxy, JSW Energy

Biocon | Bharti Infratel | SKS Microfinance | Ambuja Cements | Ranbaxy Labs | PNB | Ashok Leyland | Glenmark Pharma | Ambuja Cements | Mirc Electronics | PI Industries | Rajshree Sugars | Indiabulls Housing Finance | Birla Precision Technologies | TVS Motor | ...
 Money Control3 days ago Stocks in news: Wipro, TVS Motor, Cairn, Concor, LT Fin  Moneycontrol.com4 days ago Top 10 stocks to focus on June 30  Money Control4 weeks ago Top10 stocks to watch out for in trade today  Money Control2 months ago

Glenmark continues to struggle in US

Glenmark Pharmaceutical's 20 per cent sales growth in the June quarter suggests the company lacks any major growth trigger in FY15. Sales growth in the first quarter has been marred by anaemic growth in the US, as no new products have been launched. While ...
 Sify2 days ago Glenmark faces up to slower US growth  Livemint.com3 days ago Pharma cos to show 24% sales growth in Q1FY15: BoA-ML  MyIris3 weeks ago

Glenmark Q1 PAT may rise 26.3% at Rs 164.9 cr: P Lilladher

P Sales are expected to decrease by 0.8 percent quarter-on-quarter (growth of 34.8 percent Y-o-Y) to Rs 1668.6 crore, according to Prabhudas Lilladher. Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by ...
 Moneycontrol.com4 days ago Glenmark may post Q1 bottomline growth at 29%: Poll  Money Control4 days ago

Pharma shares in demand; Healthcare index hits new high

Sun Pharma, Ranbaxy, Dr Reddy's Lab, Lupin, Glenmark, Wockhardt and Cadila Healtchare gained 1-8% on BSE.
 Business Standard2 days ago Healthcare and pharma: Fear of pricing action  Financial Express3 weeks ago Lupin, Dr Reddys Lab top picks in pharma space: ICICIdirect  Money Control2 weeks ago

Dr Reddy's, Glenmark, Ranbaxy to get astro support: Gupta

According to Satish Gupta of, pharma stocks like Dr Reddy's Laboratories, Glenmark Pharma, Shasun Pharmaceuticals and Ranbaxy Laboratories will be getting astrological support.
 Money Control3 days ago Lupin, Wockhardt, Glenmark to get astro support: Gupta  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less